Synergistic Polyherbal–Antibiotic Combinations: Emerging Trends, Mechanisms, and Therapeutic Implications in Antimicrobial Research

Authors

  • Neelakshi Sharma Department of Pharmacy, Royal School of Pharmacy, The Assam Royal Global University, Betkuchi, Guwahati-781035, Kamrup, Assam, India.
  • Bipul Nath Department of Pharmacy, Royal School of Pharmacy, The Assam Royal Global University, Betkuchi, Guwahati-781035, Kamrup, Assam, India.
  • Payal Dasgupta Department of Pharmacy, Royal School of Pharmacy, The Assam Royal Global University, Betkuchi, Guwahati-781035, Kamrup, Assam, India.
  • Chayanika Talukdar Department of Pharmacy, Royal School of Pharmacy, The Assam Royal Global University, Betkuchi, Guwahati-781035, Kamrup, Assam, India.
  • Manas Jyoti Kapil Institute of Pharmacy, Assam Don Bosco University, Tapesia Gardens, Sonapur-782402, Kamrup, Assam, India.
  • Amaryllis Langbang Department of Biosciences, School of Life Science, Assam Don Bosco University, Tapesia Gardens, Sonapur-782402, Kamrup, Assam, India.

DOI:

https://doi.org/10.47552/ijam.v17i2.6703

Keywords:

Polyherbal formulations, Antibiotic synergy, Antimicrobial resistance, Phytochemicals, Herb–drug interactions, Nanotechnology in therapeutics

Abstract

Antimicrobial resistance (AMR) has become a pressing global health concern, threatening the efficacy of existing antibiotic therapies and complicating infection management. The indiscriminate and prolonged use of antimicrobial agents has accelerated the emergence of multidrug-resistant (MDR) pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae. These organisms employ complex resistance mechanisms including enzymatic degradation, efflux pump activation, target modification, and biofilm formation that render conventional antibiotics increasingly ineffective. With a stagnating pipeline for novel antibiotic discovery, alternative strategies are urgently required to restore antimicrobial potency and ensure therapeutic sustainability. Polyherbal formulations, integral to traditional medical systems like Ayurveda, Siddha, and Traditional Chinese Medicine, have recently gained scientific prominence as complementary interventions in antimicrobial therapy. Enriched with structurally diverse phytoconstituents such as alkaloids, flavonoids, terpenoids, and phenolics, these formulations exhibit multi-targeted actions including membrane disruption, inhibition of virulence determinants, modulation of quorum sensing, and enhancement of antibiotic penetration. When combined with conventional antibiotics, polyherbal formulations often demonstrate synergistic effects that amplify antibacterial efficacy, reduce effective antibiotic dosages, and mitigate the emergence of resistance. Accumulating in vitro and in vivo evidence supports the potential of these combinations in addressing therapeutic failures linked to MDR infections. Nevertheless, critical challenges persist concerning phytochemical standardization, mechanistic elucidation, toxicological profiling, and regulatory harmonization. Future research integrating nanotechnology, green synthesis approaches, and targeted delivery systems could further enhance the bioavailability, stability, and site-specific activity of polyherbal–antibiotic combinations. In summary, the synergistic integration of polyherbal formulations with antibiotics represents a promising and sustainable paradigm in antimicrobial research bridging traditional phytotherapy with contemporary pharmacological innovation to counter the escalating threat of AMR.

Downloads

Published

2026-09-30

How to Cite

Sharma, N., Nath, B., Dasgupta, P., Talukdar, C., Kapil, M. J., & Langbang, A. (2026). Synergistic Polyherbal–Antibiotic Combinations: Emerging Trends, Mechanisms, and Therapeutic Implications in Antimicrobial Research. International Journal of Ayurvedic Medicine, 17(3), 598–607. https://doi.org/10.47552/ijam.v17i2.6703

Issue

Section

Review Articles